Font-Porterias Neus, Giménez Aaron, Carballo-Mesa Annabel, Calafell Francesc, Comas David
Departament de Ciències Experimentals i de la Salut, Institut de Biologia Evolutiva (UPF-CSIC), Universitat Pompeu Fabra, Barcelona, Spain.
Facultat de Sociologia, Universitat Autònoma de Barcelona, Barcelona, Spain.
Front Genet. 2021 Jun 16;12:683880. doi: 10.3389/fgene.2021.683880. eCollection 2021.
Genetic patterns of inter-population variation are a result of different demographic and adaptive histories, which gradually shape the frequency distribution of the variants. However, the study of clinically relevant mutations has a Eurocentric bias. The Romani, the largest transnational minority ethnic group in Europe, originated in South Asia and received extensive gene flow from West Eurasia. Most medical genetic studies have only explored founder mutations related to Mendelian disorders in this population. Here we analyze exome sequences and genome-wide array data of 89 healthy Spanish Roma individuals to study complex traits and disease. We apply a different framework and focus on variants with both increased and decreased allele frequencies, taking into account their local ancestry. We report several OMIM traits enriched for genes with deleterious variants showing increased frequencies in Roma or in non-Roma (e.g., obesity is enriched in Roma, with an associated variant linked to South Asian ancestry; while non-insulin dependent diabetes is enriched in non-Roma Europeans). In addition, previously reported pathogenic variants also show differences among populations, where some variants segregating at low frequency in non-Roma are virtually absent in the Roma. Lastly, we describe frequency changes in drug-response variation, where many of the variants increased in Roma are clinically associated with metabolic and cardiovascular-related drugs. These results suggest that clinically relevant variation in Roma cannot only be characterized in terms of founder mutations. Instead, we observe frequency differences compared to non-Roma: some variants are absent, while other have drifted to higher frequencies. As a result of the admixture events, these clinically damaging variants can be traced back to both European and South Asian-related ancestries. This can be attributed to a different prevalence of some genetic disorders or to the fact that genetic susceptibility variants are mostly studied in populations of European descent, and can differ in individuals with different ancestries.
群体间变异的遗传模式是不同人口统计学和适应性历史的结果,这些历史逐渐塑造了变异的频率分布。然而,对临床相关突变的研究存在以欧洲为中心的偏见。罗姆人是欧洲最大的跨国少数族裔群体,起源于南亚,并从西欧亚大陆获得了广泛的基因流动。大多数医学遗传学研究仅探索了该群体中与孟德尔疾病相关的奠基者突变。在这里,我们分析了89名健康西班牙罗姆人的外显子组序列和全基因组阵列数据,以研究复杂性状和疾病。我们应用了一个不同的框架,关注等位基因频率增加和减少的变异,并考虑它们的本地祖先。我们报告了几个在线孟德尔遗传人类疾病数据库(OMIM)性状,这些性状在具有有害变异的基因中富集,这些变异在罗姆人或非罗姆人中频率增加(例如,肥胖在罗姆人中富集,有一个与南亚血统相关的变异;而非胰岛素依赖型糖尿病在非罗姆欧洲人中富集)。此外,先前报道的致病变异在不同群体中也存在差异,一些在非罗姆人中以低频分离的变异在罗姆人中几乎不存在。最后,我们描述了药物反应变异的频率变化,其中许多在罗姆人中增加的变异在临床上与代谢和心血管相关药物有关。这些结果表明,罗姆人中的临床相关变异不能仅用奠基者突变来表征。相反,与非罗姆人相比,我们观察到频率差异:一些变异不存在,而其他变异则漂移到更高的频率。由于混合事件,这些具有临床损害性的变异可以追溯到欧洲和南亚相关的祖先。这可能归因于一些遗传疾病的不同患病率,或者是由于遗传易感性变异大多在欧洲血统人群中进行研究,并且在不同血统的个体中可能有所不同。